<DOC>
	<DOCNO>NCT01412151</DOCNO>
	<brief_summary>The purpose study extend finding creatine dose-finding study ( CREST-UP1 ) Huntington 's disease evaluate long-term safety , tolerability , clinical impact high dose creatine .</brief_summary>
	<brief_title>Creatine Safety &amp; Tolerability Huntington 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Huntington Disease</mesh_term>
	<criteria>Individuals complete CRESTUP1 study . Individuals able take oral medication . Individuals capable provide informed consent comply trial procedure . History known sensitivity intolerability creatine . Clinical evidence unstable medical illness investigator 's judgment . Additional eligibility criterion apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Symptomatic</keyword>
	<keyword>Huntington 's Disease</keyword>
	<keyword>HD</keyword>
</DOC>